| |
| |
|
| Insider
Information: |
Dubensky Thomas W. |
| Relationship: |
President, Director |
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
153,243 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,731,705 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
153,243 |
|
|
| Total
Value |
$1,731,705 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chinook Therapeutics Inc |
KDNY |
Chief Scientific Officer |
2017-08-11 |
39,900 |
2015-11-16 |
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
President, Director |
2022-01-07 |
113,343 |
2021-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TPST |
Tempest Therapeutics, Inc |
President |
• • – |
2022-01-07 |
4 |
B |
$4.78 |
$9,560 |
D/D |
2,000 |
113,343 |
2.81 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
President |
• • – |
2021-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
111,343 |
111,343 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-08-11 |
4 |
AS |
$11.17 |
$101,538 |
D/D |
(9,088) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-08-11 |
4 |
OE |
$1.00 |
$9,088 |
D/D |
9,088 |
48,988 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-08-10 |
4 |
AS |
$11.43 |
$467,665 |
D/D |
(40,912) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-08-10 |
4 |
OE |
$1.00 |
$40,912 |
D/D |
40,912 |
80,812 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-07-06 |
4 |
OE |
$0.52 |
$2,346 |
D/D |
4,512 |
44,412 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-07-06 |
4 |
AS |
$11.23 |
$50,673 |
D/D |
(4,512) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-07-05 |
4 |
AS |
$11.46 |
$385,936 |
D/D |
(33,688) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-07-05 |
4 |
OE |
$0.52 |
$17,518 |
D/D |
33,688 |
73,588 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-07-03 |
4 |
AS |
$11.02 |
$130,028 |
D/D |
(11,800) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-07-03 |
4 |
OE |
$0.52 |
$6,136 |
D/D |
11,800 |
51,700 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-06-05 |
4 |
OE |
$0.52 |
$9,140 |
D/D |
17,577 |
57,477 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-06-05 |
4 |
AS |
$9.99 |
$175,628 |
D/D |
(17,577) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-06-02 |
4 |
AS |
$10.10 |
$492,283 |
D/D |
(48,753) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-06-02 |
4 |
OE |
$0.52 |
$25,352 |
D/D |
48,753 |
88,653 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-06-01 |
4 |
OE |
$0.52 |
$40,545 |
D/D |
77,971 |
117,871 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-06-01 |
4 |
AS |
$10.00 |
$779,866 |
D/D |
(77,971) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-05-12 |
4 |
AS |
$9.92 |
$42,658 |
D/D |
(4,299) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-05-12 |
4 |
OE |
$0.52 |
$2,235 |
D/D |
4,299 |
44,199 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-05-11 |
4 |
AS |
$9.91 |
$13,870 |
D/D |
(1,400) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-05-11 |
4 |
OE |
$0.52 |
$728 |
D/D |
1,400 |
41,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-03-09 |
4 |
AS |
$10.96 |
$274,078 |
D/D |
(25,000) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-03-09 |
4 |
OE |
$0.52 |
$19,446 |
D/D |
25,000 |
64,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-01-03 |
4 |
AS |
$11.16 |
$278,990 |
D/D |
(25,000) |
39,900 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
